Skip to Main Content

Author Details

Anne M Kelly
Addenbrooke's Hospital
2011
22
16
PMIDPaper TitleJournal TitlePublished Year
33216967The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.Br J Haematol2021
33216967The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.Br J Haematol2021
34650880Severe Thrombocytopenia in a Case of Epstein-Barr Virus-Induced Infectious Mononucleosis.Cureus2021
34650880Severe Thrombocytopenia in a Case of Epstein-Barr Virus-Induced Infectious Mononucleosis.Cureus2021
31278078Fifteen-minute consultation: Initial management of suspected acute leukaemia by non-specialists.Arch Dis Child Educ Pract Ed2020
31747136Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment.Int J Lab Hematol2020
31822811Oral verruciform xanthoma associated with stem cell transplantation and graft versus host disease in a paediatric patient.Bone Marrow Transplant2020
32390158Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B.Br J Haematol2020
32693407Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.Blood2020
31278078Fifteen-minute consultation: Initial management of suspected acute leukaemia by non-specialists.Arch Dis Child Educ Pract Ed2020
31747136Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment.Int J Lab Hematol2020
31822811Oral verruciform xanthoma associated with stem cell transplantation and graft versus host disease in a paediatric patient.Bone Marrow Transplant2020
32693407Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome.Blood2020
32390158Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B.Br J Haematol2020
28064200Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.Blood2017
28487294The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.Blood2017
28612348Juvenile myelomonocytic leukemia in an infant with congenital human immunodeficiency virus and cytomegalovirus infection.Am J Hematol2017
28064200Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.Blood2017
28001309Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time.Vox Sang2017
28487294The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial.Blood2017
28612348Juvenile myelomonocytic leukemia in an infant with congenital human immunodeficiency virus and cytomegalovirus infection.Am J Hematol2017
28001309Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time.Vox Sang2017
27084890A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.Blood2016
26912466A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.Blood2016
27084890A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.Blood2016
26936507A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.Sci Transl Med2016
26912466A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.Blood2016
26936507A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.Sci Transl Med2016
25301082Neonatal thrombocytopenia and platelet transfusion - a UK perspective.Neonatology2015
25301082Neonatal thrombocytopenia and platelet transfusion - a UK perspective.Neonatology2015
25949529Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders.Genome Med2015
25949529Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders.Genome Med2015
24217912The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data.Nucleic Acids Res2014
25258084Transcriptional diversity during lineage commitment of human blood progenitors.Science2014
24217912The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data.Nucleic Acids Res2014
24117481Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.Transfusion2014
24509480Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.Nat Genet2014
25258084Transcriptional diversity during lineage commitment of human blood progenitors.Science2014
24509480Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.Nat Genet2014
24117481Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.Transfusion2014
24095206Neonatal transfusion.Early Hum Dev2013
24095206Neonatal transfusion.Early Hum Dev2013
21391974Human immunodeficiency virus associated thrombotic thrombocytopenic purpura--favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy.Br J Haematol2011
21391974Human immunodeficiency virus associated thrombotic thrombocytopenic purpura--favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy.Br J Haematol2011
  • 1 - 44 of 44

Recommended Authors

Royal Children's Hospital
Career Start Year 2011
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2009
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Johns Hopkins University
Career Start Year 2007
Number of shared co-authors 0
Christian Medical College
Career Start Year 2007
Number of shared co-authors 1
Yale University School of Medicine, Yale-New Haven Hospital
Career Start Year 2007
Number of shared co-authors 0
University of New Mexico
Career Start Year 2006
Number of shared co-authors 0
Children's National Hospital
Career Start Year 2003
Number of shared co-authors 1
John R. Oishei Children's Hospital of Buffalo
Career Start Year 2002
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2001
Number of shared co-authors 1
Carver College of Medicine, University of Iowa
Career Start Year 1999
Number of shared co-authors 1
Nationwide Children's Hospital
Career Start Year 1998
Number of shared co-authors 0
University Health Network
Career Start Year 1996
Number of shared co-authors 1
University of Wisconsin School of Medicine and Public Health
Career Start Year 1994
Number of shared co-authors 0
Hospital
Career Start Year 1992
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
University of New Mexico School of Medicine
Career Start Year 1992
Number of shared co-authors 1
University of Minnesota
Career Start Year 1990
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1990
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 1988
Number of shared co-authors 0
Stony Brook Renaissances School of Medicine, Stony Brook University
Career Start Year 1984
Number of shared co-authors 1
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 0
Children's Research National Institute, Children's National Hospital
Career Start Year 1978
Number of shared co-authors 1
Johns Hopkins University
Career Start Year 1974
Number of shared co-authors 0
Clinical Center, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1974
Number of shared co-authors 0
University of Iowa Carver College of Medicine
Career Start Year 1969
Number of shared co-authors 1

Collaborators

University of Cambridge
Co-authored papers 10
Center for Molecular and Vascular Biology, University of Leuven
Co-authored papers 8
University of Bristol
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
University of Cambridge
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Genomics England Ltd
Co-authored papers 5
National Health Service Blood and Transplant, University of Cambridge
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
University of Cambridge
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Cambridge University Hospitals NHS Foundation
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
University of Cambridge, UK Cambridge University Hospitals NHS Foundation Trust
Co-authored papers 2
University of Cambridge
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2